Back
Denali Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison
Sell
43
DNLI
Denali Therapeutics
Last Price:
$21.23
Seasonality Move:
-5.71%
Sell
26
NVO
Novo Nordisk AS
Last Price:
$87.66
Seasonality Move:
6.4%
Sell
43
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy, Sell or Hold?
-
The current Denali Therapeutics [DNLI] share price is $21.26. The Score for DNLI is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
DNLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $87.65. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $21.26Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.23 | Sell |
Relative Strength Index (14 RSI): | 39.04 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.03 - 24.45) | Sell |
Bollinger Bands (100): | (22.97 - 28.69) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.01 | Sell |
Relative Strength Index (14 RSI): | 30.1 | Sell |
Chaikin Money Flow: | -992739 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.25 - 110.97) | Sell |
Bollinger Bands (100): | (101.58 - 130.52) | Sell |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.79 | Buy |
20-day SMA: | 22.26 | Sell |
50-day SMA: | 24.87 | Sell |
200-day SMA: | 23.06 | Sell |
8-day EMA: | 21.04 | Buy |
20-day EMA: | 22.1 | Sell |
50-day EMA: | 23.92 | Sell |
200-day EMA: | 23.85 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 87.25 | Buy |
20-day SMA: | 98.78 | Sell |
50-day SMA: | 104.32 | Sell |
200-day SMA: | 124.42 | Sell |
8-day EMA: | 89.14 | Sell |
20-day EMA: | 95.42 | Sell |
50-day EMA: | 103.78 | Sell |
200-day EMA: | 115.72 | Sell |
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.80 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $0.66 per share.
Denali Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |